Lantern Pharma Stock Alpha and Beta Analysis
| LTRN Stock | USD 3.82 0.10 2.69% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Lantern Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Lantern Pharma over a specified time horizon. Remember, high Lantern Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Lantern Pharma's market risk premium analysis include:
Beta 0.73 | Alpha 0.39 | Risk 6.57 | Sharpe Ratio 0.0893 | Expected Return 0.59 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Lantern |
Lantern Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Lantern Pharma market risk premium is the additional return an investor will receive from holding Lantern Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lantern Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Lantern Pharma's performance over market.| α | 0.39 | β | 0.73 |
Lantern Pharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Lantern Pharma's Buy-and-hold return. Our buy-and-hold chart shows how Lantern Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Lantern Pharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Lantern Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lantern Pharma shares will generate the highest return on investment. By understating and applying Lantern Pharma stock market price indicators, traders can identify Lantern Pharma position entry and exit signals to maximize returns.
Lantern Pharma Return and Market Media
The median price of Lantern Pharma for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 is 3.89 with a coefficient of variation of 15.0. The daily time series for the period is distributed with a sample standard deviation of 0.61, arithmetic mean of 4.04, and mean deviation of 0.5. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Lantern Pharma Extends CSOs Employment Agreement - TipRanks | 01/10/2025 |
2 | Lantern Pharma Inc. Enhances RADR AI Platform to Accelerate Development of Antibody-Drug Conjugates for Targeted Cancer Therapies | 01/27/2025 |
3 | Disposition of 6944 shares by Kreis Leslie W. of Lantern Pharma at 6.25 subject to Rule 16b-3 | 02/11/2025 |
4 | Will Lantern Pharma Spend Its Cash Wisely | 02/21/2025 |
5 | Acquisition by Keyser D Jeffrey of 3832 shares of Lantern Pharma at 3.13 subject to Rule 16b-3 | 03/07/2025 |
6 | LTRN MA Illuminates GBM Value | 03/10/2025 |
7 | Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating Financial Results on March 27th, 2025 at 430 p.m. ET | 03/20/2025 |
About Lantern Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Lantern or other stocks. Alpha measures the amount that position in Lantern Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | |
| Current Ratio | 20.99 | 16.18 | 14.56 | 14.43 |
| Net Debt To EBITDA | 2.58 | 1.37 | 1.24 | 1.62 |
Lantern Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Lantern Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lantern Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Lantern Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Lantern Pharma. Please utilize our Beneish M Score to check the likelihood of Lantern Pharma's management manipulating its earnings.
| 18th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 18th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Lantern Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Lantern Pharma Backtesting, Lantern Pharma Valuation, Lantern Pharma Correlation, Lantern Pharma Hype Analysis, Lantern Pharma Volatility, Lantern Pharma History and analyze Lantern Pharma Performance. To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Lantern Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.